Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial
fibrillation monitoring. Data from stroke registries show that both unknown and untreated or …

Atrial fibrillation (AF) is a common arrhythmia that is associated with substantial morbidity
and mortality, particularly due to stroke and thromboembolism. Anticoagulant therapy …

Ischemic strokes related to atrial fibrillation are highly prevalent, presenting with severe
neurologic syndromes and associated with high risk of recurrence. Although advances have …

Background and Purpose—Warfarin is the most effective stroke prevention medication for
high-risk individuals with atrial fibrillation, yet it is often underused. This study examined the …

The world faces an epidemic of atrial fibrillation and atrial fibrillation-related stroke. An
individual's risk of atrial fibrillation-related stroke can be estimated with the CHADS 2 or CHA …

Concepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed
markedly over the last decade. There has been an evolution over the approach to stroke and …

Aims Underuse of warfarin for stroke prophylaxis in atrial fibrillation (AF) is extensive and
represents a major problem in clinical practice. To identify factors associated with warfarin …

Importance Atrial fibrillation (AF) is associated with an increase in mortality and morbidity,
with a substantial increase in stroke and systemic thromboembolism. Strokes related to AF …

Atrial fibrillation (AF) is an important risk factor for stroke. According to a pooled analysis of
controlled clinical trials with warfarin, anticoagulation therapy reduces stroke risk by 62 …

ContextWarfarin has been shown to be highly efficacious for preventing thromboembolism in
atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is …